EMA - CTIS Designated as a Primary Registry

3rd April 2025

EMA - CTIS Designated as a Primary Registry

EMA is pleased to announce that CTIS has been designated as a primary registry by the World Health Organisation (WHO) within the International Clinical Trials Registry Platform (ICTRP). The WHO International Clinical Trials Registry Platform aims to ensure that comprehensive research information is accessible to healthcare decision makers globally.

This milestone represents a significant advancement in facilitating data sharing and promoting transparency and trust in clinical research.

Back to Recent News